PTO Explains Proposed Guidelines

When inventors apply for a patent, they must set forth the utility of their invention and describe it. Which utilities and description meet the grade, and which don't? The U.S. Patent and Trademark Office (PTO) recently proposed new guidelines for its examiners. These guidelines were discussed in an article titled "Biotech Faces Evolving Patent System" in the last issue of The Scientist.1 PTO had not at that time published specific examples of how the guidelines would be interpreted. The office

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

When inventors apply for a patent, they must set forth the utility of their invention and describe it. Which utilities and description meet the grade, and which don't? The U.S. Patent and Trademark Office (PTO) recently proposed new guidelines for its examiners. These guidelines were discussed in an article titled "Biotech Faces Evolving Patent System" in the last issue of The Scientist.1 PTO had not at that time published specific examples of how the guidelines would be interpreted. The office did so on March 1, issuing training materials replete with examples, most of which pertain to biotech (www.uspto.gov).

In focusing on the "genus" and "species" of a claimed invention, the written-description examples are legally and scientifically complex. They're best discussed with a patent agent or lawyer. The utility examples (www.uspto.gov/web/offices/pac/utility/utilityguide.pdf.) should also be explained by a professional but are generally more colorful and approachable. Here are some of their do's ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Douglas Steinberg

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours